Cadila Re­calls 10K Bot­tles of Anti-al­lergy Drug in US

The Economic Times - - Companies -

Cadila Health­care is re­call­ing over 10,000 bot­tles of an anti-al­lergy drug in the US be­cause of a mix-up in tablets. Zy­dus Phar­ma­ceu­ti­cals USA, a unit of the com­pany, is re­call­ing 10,200 bot­tles of promet­hazine hy­drochlo­ride tablets that con­tain for­eign tablets, ac­cord­ing to in­for­ma­tion on the US Food and Drug Ad­min­is­tra­tion (FDA) web­site. The re­call is due to the “pres­ence of atenolol 25 mg tablet mixed into promet­hazine 25 mg tablet bot­tles,” the FDA said. The na­tion­wide re­call was ini­ti­ated on May 8. The 25-mg tablets in 100-count bot­tles were man­u­fac­tured by Cadila Health­care and dis­trib­uted in the US mar­ket by Zy­dus Phar­ma­ceu­ti­cals, it added.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.